How Ph.D. was paid
$1.6M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Jacqueline E. Shea, Ph.D.President and Chief Executive Officer | $728,000 | $346,101 | $351,955 | $144,144 | $16,955 | $1,587,155 |
| Michael Sumner, M.D.Chief Medical Officer and Head of Development | $548,708 | $127,607 | $129,554 | $87,392 | $17,375 | $910,636 |
| Peter D. KiesChief Financial Officer | $514,604 | $117,479 | $117,927 | $68,236 | $15,438 | $833,684 |
What changed and why
- $1.6MCEO total compensation decreased to $1,587,155 in 2025 compared to $2,050,669 in 2024.
- 33%Named executive officer annual cash incentive bonuses were paid at 33% of targeted amounts for 2025 performance.
- Stock and option awards for executives reflect grant date fair values computed under FASB ASC Topic 718.
- 87%Say-on-pay support increased to 87% at the 2025 annual meeting of stockholders.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.